PopVax

Hyderabad, India Founded: 2021 • Age: 5 yrs
Developer of mRNA platform for vaccines and therapeutics

About PopVax

PopVax is a Healthcare company based in Hyderabad (India) founded in 2021 by Soham Sankaran. The company has 49 employees. Its Indian entity Popvax Private Limited reported revenue of β‚Ή56.94 Cr. PopVax offers products and services including mRNA Vaccines, LNP Delivery Platform, and Therapeutics Platform. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics.

Company details

Developer of mRNA platform for vaccines and therapeutics. It offers multivariant thermostable vaccine for SARS-CoV-2 treatment.

  • Headquarters Hyderabad, India
  • Employees 49
  • Founders Soham Sankaran
  • Sectors
    Healthcare
  • Website popvax.com
  • Social X
  • Legal Name Popvax Private Limited
  • Date of Incorporation 26 Jul, 2021
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹56.94 Cr

    FY 2025 · +45% YoY

  • Net Profit
    ₹1.03 Cr

    FY 2025 · 2% margin

  • EBITDA
    ₹9.18 Cr

    FY 2025 · 16% margin

  • Latest Funding Round
    $3.6M (USD), Grant

    Sep 2025

  • Investors
    BARDA

    & 1 more

  • Employee Count
    49

Products & Services of PopVax

PopVax offers a comprehensive portfolio of products and services, including mRNA Vaccines, LNP Delivery Platform, and Therapeutics Platform.

mRNA Vaccines
Vaccine Development

Designs vaccines for COVID-19 and other pathogens using computational methods.

LNP Delivery Platform
Drug Delivery

Provides mRNA delivery with novel ionizable lipids for therapeutic applications.

Therapeutics Platform
Biomedicine

Develops treatments for chronic infections and diseases via protein design.

Funding Insights of PopVax

  • Total Rounds 2
  • Last Round Grant β€” $3.6M
  • First Round $2M

    (Jan 2025)

  • Investors Count 2

All 2 funding rounds of PopVax with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2025$3.6MGrant––
Jan 2025$2MGrant––
Valuation history

2 investors in total: 2 institutional.

Investors in PopVax

PopVax has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include BARDA and Gates Foundation.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
BARDA is focused on developing medical countermeasures for public health security.
medicalcountermeasures.govUnited States
Charitable foundation investments on poverty reduction and healthcare
gatesfoundation.org
Premium access

Investor details for PopVax

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Popvax Private Limited (PopVax)

Popvax Private Limited is the primary company behind PopVax. The board of Popvax Private Limited currently have 2 directors; the longest-serving is Sahaj Govindarajan Sankaran, appointed in 2021. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Sahaj Govindarajan Sankaran
DIN 09254190
Director26 Jul 20215 yrs 3 moPopvax Private Limited
Soham Govindarajan Sankaran
DIN 09254191
Managing Director26 Jul 20215 yrs 3 moPopvax Private Limited

People of PopVax

4 people are tracked at PopVax (3 in leadership, 1 in team); the tracked headcount is 49.

NameRoleGroup
FounderLeadership
Praveen Vittala Kumar
VP Quality And Analytical SciencesLeadership
Dr Tushar Ranjan Moharana
Vice President - Protein DesignLeadership
Gayathri Vijay
Senior Manager - Operations And Supply ChainTeam
Premium access

Complete people profiles for PopVax

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of PopVax

Figures of Popvax Private Limited, the primary company behind PopVax, for FY 2025. Revenue was ₹56.94 Cr (+45% year on year). Net profit was ₹1.03 Cr (2% margin). EBITDA was ₹9.18 Cr (16% margin). Revenue has grown at a compounded annual rate of +257% over three years.

  • ₹56.94 CrRevenue · FY 2025 · +45% YoY
  • ₹1.03 CrNet profit · 2% margin
  • ₹9.18 CrEBITDA · 16% margin
  • ₹1 LakhPaid-up capital
  • 49Employees (provident fund records)
  • +257%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Popvax Private Limited are on its company page.

Premium access

Detailed financial statements for PopVax

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of PopVax

3 dated milestones of PopVax across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded PopVax is founded.
  2. Funding First funding round of $2.0M.
  3. Funding Latest funding round, Grant, of $3.6M.

Web traffic of PopVax

The website of PopVax (popvax.com) receives about 8.8K visits a month.

  • Monthly visits
    8.8K

    ▲ 114.2% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Popvax

Premium access

Complete news archive for PopVax

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PopVax

PopVax was founded in 2021 and raised its 1st funding round 4 years after it was founded.

PopVax is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

PopVax has 49 employees.

The primary company behind PopVax, Popvax Private Limited, reported revenue of β‚Ή56.94 Cr for FY 2025, up 45% year on year.

Developer of mRNA platform for vaccines and therapeutics. It offers multivariant thermostable vaccine for SARS-CoV-2 treatment.

PopVax offers mRNA Vaccines, LNP Delivery Platform, and Therapeutics Platform.

PopVax has 2 investors. Key investors include BARDA, and Gates Foundation.

PopVax operates through Popvax Private Limited.

The legal entities of PopVax currently have 2 directors, including Sahaj Govindarajan Sankaran, Soham Govindarajan Sankaran.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available